Catherine J. Mummery

8.7k total citations
78 papers, 3.3k citations indexed

About

Catherine J. Mummery is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Catherine J. Mummery has authored 78 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cognitive Neuroscience, 19 papers in Psychiatry and Mental health and 18 papers in Physiology. Recurrent topics in Catherine J. Mummery's work include Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (16 papers) and Neurobiology of Language and Bilingualism (9 papers). Catherine J. Mummery is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Dementia and Cognitive Impairment Research (16 papers) and Neurobiology of Language and Bilingualism (9 papers). Catherine J. Mummery collaborates with scholars based in United Kingdom, United States and Sweden. Catherine J. Mummery's co-authors include Eleanor A. Maguire, Jason D. Warren, Richard G. Wise, Jonathan M. Schott, Nick C. Fox, Karalyn Patterson, Martin N. Rossor, C.J. Price, John R. Hodges and J. R. Hodges and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Catherine J. Mummery

76 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine J. Mummery United Kingdom 26 1.9k 872 608 505 466 78 3.3k
Fabrizio Piras Italy 36 1.6k 0.9× 958 1.1× 314 0.5× 647 1.3× 220 0.5× 111 3.5k
Gabriel Leonard Canada 38 1.8k 1.0× 485 0.6× 476 0.8× 196 0.4× 272 0.6× 80 4.5k
Karen Caeyenberghs Australia 41 2.5k 1.3× 1.0k 1.2× 250 0.4× 608 1.2× 919 2.0× 146 5.0k
Robert Laforce Canada 26 1.1k 0.6× 1.1k 1.3× 717 1.2× 417 0.8× 186 0.4× 117 2.6k
Brian T. Gold United States 35 3.1k 1.7× 878 1.0× 529 0.9× 215 0.4× 785 1.7× 109 4.7k
Jennifer M. Ogar United States 22 2.8k 1.5× 1.3k 1.5× 820 1.3× 594 1.2× 931 2.0× 24 3.7k
Maya L. Henry United States 36 3.3k 1.8× 1.4k 1.6× 860 1.4× 459 0.9× 1.3k 2.7× 86 4.5k
Kirk R. Daffner United States 42 3.2k 1.7× 1.4k 1.6× 507 0.8× 240 0.5× 257 0.6× 124 5.2k
Simona M. Brambati Canada 38 3.4k 1.8× 1.6k 1.8× 745 1.2× 613 1.2× 1.1k 2.4× 104 4.5k
Francesca Baglio Italy 32 1.0k 0.6× 763 0.9× 341 0.6× 620 1.2× 180 0.4× 177 3.3k

Countries citing papers authored by Catherine J. Mummery

Since Specialization
Citations

This map shows the geographic impact of Catherine J. Mummery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine J. Mummery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine J. Mummery more than expected).

Fields of papers citing papers by Catherine J. Mummery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine J. Mummery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine J. Mummery. The network helps show where Catherine J. Mummery may publish in the future.

Co-authorship network of co-authors of Catherine J. Mummery

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine J. Mummery. A scholar is included among the top collaborators of Catherine J. Mummery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine J. Mummery. Catherine J. Mummery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joie, Renaud La, Jeffrey L. Cummings, Jeffrey L. Dage, et al.. (2025). Treatment‐related amyloid clearance (TRAC): a framework to characterize patients in the era of anti‐amyloid therapies. Alzheimer s & Dementia. 21(11). e70997–e70997. 2 indexed citations
2.
Jakabek, David, Adrian M. Isaacs, Bart De Strooper, et al.. (2025). CTAD taskforce: genetic therapies in Alzheimer’s disease. The Journal of Prevention of Alzheimer s Disease. 12(8). 100269–100269. 1 indexed citations
3.
Perneczky, Robert, David Darby, Giovanni B. Frisoni, et al.. (2025). Real-world datasets for the International Registry for Alzheimer's Disease and Other Dementias (InRAD) and other registries: An international consensus. The Journal of Prevention of Alzheimer s Disease. 12(4). 100096–100096. 3 indexed citations
4.
Camic, Paul M., Emma Harding, Mary Pat Sullivan, et al.. (2025). “A torch, a rope, a belly laugh”: engaging with the multiple voices of support groups for people living with rare dementia. PubMed. 3. 1488025–1488025. 1 indexed citations
5.
Lane, Roger, Taher Darreh‐Shori, Candice Junge, et al.. (2024). Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers. BMC Neurology. 24(1). 116–116. 2 indexed citations
7.
8.
Hardy, John & Catherine J. Mummery. (2023). An anti-amyloid therapy works for Alzheimer’s disease: why has it taken so long and what is next?. Brain. 146(4). 1240–1242. 32 indexed citations
9.
Knight, Jo, Rejith Dayanandan, Anthony G Marson, et al.. (2023). Outpatient neurology diagnostic coding: a proposed scheme for standardised implementation. Practical Neurology. 23(4). 317–322.
10.
Keshavan, Ashvini, Miles Chapman, Melanie Hart, et al.. (2022). CSF biomarkers for dementia. Practical Neurology. 22(4). 285–294. 8 indexed citations
11.
O’Connor, Antoinette, Emily K. Abel, Natalie S. Ryan, et al.. (2021). A novel presenilin 1 duplication mutation (Ile168dup) causing Alzheimer's disease associated with myoclonus, seizures and pyramidal features. Neurobiology of Aging. 103. 137.e1–137.e5. 3 indexed citations
12.
LaMontagne, Pamela, Matthew F. Glasser, Randall J. Bateman, et al.. (2021). Regional age-related atrophy after screening for preclinical alzheimer disease. Neurobiology of Aging. 109. 43–51. 9 indexed citations
13.
Lynch, David S., Anderson Rodrigues Brandão de Paiva, Nevin John, et al.. (2018). Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era. Journal of Neurology Neurosurgery & Psychiatry. 90(5). 543–555. 74 indexed citations
14.
Marshall, Charles R., Chris JD Hardy, Lucy L. Russell, et al.. (2017). Impaired Interoceptive Accuracy in Semantic Variant Primary Progressive Aphasia. Frontiers in Neurology. 8. 610–610. 32 indexed citations
15.
Weston, Philip S.J., Ross W. Paterson, John Dickson, et al.. (2016). Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?. Journal of Alzheimer s Disease. 54(4). 1297–1302. 18 indexed citations
16.
Fletcher, Phillip D., Jennifer M. Nicholas, Laura Downey, et al.. (2016). A physiological signature of sound meaning in dementia. Cortex. 77. 13–23. 16 indexed citations
17.
Clark, Camilla N., Jennifer M. Nicholas, Susie M.D. Henley, et al.. (2015). Humour processing in frontotemporal lobar degeneration: A behavioural and neuroanatomical analysis. Cortex. 69. 47–59. 37 indexed citations
18.
Golden, Hannah L., Jennifer L. Agustus, Johanna C. Goll, et al.. (2015). Functional neuroanatomy of auditory scene analysis in Alzheimer's disease. NeuroImage Clinical. 7. 699–708. 34 indexed citations
19.
Rossor, Martin N., Nick C. Fox, Catherine J. Mummery, Jonathan M. Schott, & Jason D. Warren. (2010). The diagnosis of young-onset dementia. The Lancet Neurology. 9(8). 793–806. 391 indexed citations
20.
Knight, W. David, John C. Kennedy, Simon Mead, et al.. (2007). A novel presenilin 1 deletion (p.L166del) associated with early onset familial Alzheimer's disease. European Journal of Neurology. 14(7). 829–831. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026